KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to 8.91%.

  • Repligen's EBIT Margin rose 139700.0% to 8.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year decrease of 16600.0%. This contributed to the annual value of 5.53% for FY2024, which is 130800.0% down from last year.
  • As of Q3 2025, Repligen's EBIT Margin stood at 8.91%, which was up 139700.0% from 7.62% recorded in Q2 2025.
  • Repligen's EBIT Margin's 5-year high stood at 30.42% during Q2 2022, with a 5-year trough of 21.79% in Q4 2024.
  • For the 5-year period, Repligen's EBIT Margin averaged around 12.72%, with its median value being 8.91% (2025).
  • Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -277100bps in 2024, then surged by 139700bps in 2025.
  • Repligen's EBIT Margin (Quarter) stood at 20.07% in 2021, then surged by 30bps to 26.15% in 2022, then plummeted by -77bps to 5.93% in 2023, then crashed by -468bps to 21.79% in 2024, then soared by 141bps to 8.91% in 2025.
  • Its EBIT Margin was 8.91% in Q3 2025, compared to 7.62% in Q2 2025 and 3.89% in Q1 2025.